Contrast media: future aspects.
In spite of the dramatic development in CT, there was no major breakthrough in the iodinated contrast media development. New agents based on hybrid between MRI and CT compounds may be a new innovative alternative. This new approach may also open new indications such as radiotherapy.
Research Laboratories, Schering AG, Müllerstrasse 178, 13342 Berlin, Germany. hannsjoachim.weinmann@schering.de
H J
HJ
Weinmann
J
J
Platzek
H
H
Schirmer
H
H
Pietsch
J
J
Carretero
J
J
Harto
J
J
Medina
B
B
Riefke
J
J
Martín
D003287:Contrast Media / Q000737:chemistry / Q000494:pharmacology*; D003952:Diagnostic Imaging / Q000639:trends*; D005682:Gadolinium / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D011878:Radiotherapy / Q000379:methods; D014283:Triiodobenzoic Acids / Q000737:chemistry / Q000494:pharmacology*
D003287:Contrast Media; D014283:Triiodobenzoic Acids; D005682:Gadolinium